Form CORRESP - Correspondence:
SEC Accession No. 0001628280-15-007098
Filing Date
2015-09-14
Accepted
2015-09-14 16:54:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 56016
  Complete submission text file 0001628280-15-007098.txt   56874
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations